Published in J Biomed Mater Res A on December 15, 2007
Engineering on the straight and narrow: the mechanics of nanofibrous assemblies for fiber-reinforced tissue regeneration. Tissue Eng Part B Rev (2009) 1.88
Review: advances in vascular tissue engineering using protein-based biomaterials. Tissue Eng (2007) 1.33
Biomaterials for vascular tissue engineering. Regen Med (2010) 1.19
New directions in nanofibrous scaffolds for soft tissue engineering and regeneration. Expert Rev Med Devices (2009) 1.00
Electrospinning of small diameter 3-D nanofibrous tubular scaffolds with controllable nanofiber orientations for vascular grafts. J Mater Sci Mater Med (2010) 0.99
Polymer nanofibrous structures: Fabrication, biofunctionalization, and cell interactions. Prog Polym Sci (2010) 0.97
A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants. Acta Biomater (2010) 0.95
The effect of controlled release of PDGF-BB from heparin-conjugated electrospun PCL/gelatin scaffolds on cellular bioactivity and infiltration. Biomaterials (2012) 0.91
Mechanical property characterization of electrospun recombinant human tropoelastin for vascular graft biomaterials. Acta Biomater (2011) 0.90
Electrospun vascular grafts with improved compliance matching to native vessels. J Biomed Mater Res B Appl Biomater (2014) 0.85
Single-walled carbon nanotubes promote rat vascular adventitial fibroblasts to transform into myofibroblasts by SM22-α expression. Int J Nanomedicine (2012) 0.83
Elastin and collagen enhances electrospun aligned polyurethane as scaffolds for vascular graft. J Mater Sci Mater Med (2013) 0.82
Development and in vivo evaluation of small-diameter vascular grafts engineered by outgrowth endothelial cells and electrospun chitosan/poly(ε-caprolactone) nanofibrous scaffolds. Tissue Eng Part A (2013) 0.79
Scanning-fiber-based imaging method for tissue engineering. J Biomed Opt (2012) 0.79
Small-diameter tissue engineered vascular graft made of electrospun PCL/lecithin blend. J Mater Sci Mater Med (2012) 0.79
Development of small diameter nanofiber tissue engineered arterial grafts. PLoS One (2015) 0.79
Improvement of cytocompatibility of electrospinning PLLA microfibers by blending PVP. J Mater Sci Mater Med (2009) 0.78
Preliminary In Vivo Evaluation of a Hybrid Armored Vascular Graft Combining Electrospinning and Additive Manufacturing Techniques. Drug Target Insights (2016) 0.78
The influence of electrospun scaffold topography on endothelial cell morphology, alignment, and adhesion in response to fluid flow. Biotechnol Bioeng (2013) 0.78
Structural and cellular characterization of electrospun recombinant human tropoelastin biomaterials. J Biomater Appl (2011) 0.78
Aspirin-loaded electrospun poly(ε-caprolactone) tubular scaffolds: potential small-diameter vascular grafts for thrombosis prevention. J Mater Sci Mater Med (2012) 0.77
Electrospinning covalently cross-linking biocompatible hydrogelators. Polymer (Guildf) (2012) 0.77
Extracellular matrix molecules facilitating vascular biointegration. J Funct Biomater (2012) 0.77
Fabricated Elastin. Adv Healthc Mater (2015) 0.76
A Facile Approach for the Mass Production of Submicro/Micro Poly (Lactic Acid) Fibrous Mats and Their Cytotoxicity Test towards Neural Stem Cells. Biomed Res Int (2016) 0.75
Electrospun PELCL membranes loaded with QK peptide for enhancement of vascular endothelial cell growth. J Mater Sci Mater Med (2016) 0.75
Bioactive polymeric scaffolds for tissue engineering. Bioact Mater (2016) 0.75
Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol (2007) 9.67
Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet (2006) 7.64
Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet (2011) 3.95
Engineering complex tissues. Tissue Eng (2006) 2.53
Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells (2004) 2.32
Carbon nanotube applications for tissue engineering. Biomaterials (2006) 2.25
Anterior urethral valves and diverticula in children: a result of ruptured Cowper's duct cyst? BJU Int (2004) 2.19
The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology (2011) 2.09
Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J Mol Cell Cardiol (2006) 1.99
Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol (2002) 1.97
Antiangiogenic properties of gold nanoparticles. Clin Cancer Res (2005) 1.78
Controlled fabrication of a biological vascular substitute. Biomaterials (2005) 1.76
Cell-seeded tubularized scaffolds for reconstruction of long urethral defects: a preclinical study. Eur Urol (2012) 1.69
Tissue engineering, stem cells, and cloning: opportunities for regenerative medicine. J Am Soc Nephrol (2004) 1.68
Implantation of autologous urine derived stem cells expressing vascular endothelial growth factor for potential use in genitourinary reconstruction. J Urol (2011) 1.56
Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials (2012) 1.55
Urine derived cells are a potential source for urological tissue reconstruction. J Urol (2008) 1.54
Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture. J Vasc Surg (2012) 1.52
The influence of electrospun aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. Biomaterials (2008) 1.47
Whole organ decellularization - a tool for bioscaffold fabrication and organ bioengineering. Conf Proc IEEE Eng Med Biol Soc (2009) 1.47
The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction. Biomaterials (2008) 1.46
Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells (2008) 1.46
Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology. Stem Cells (2013) 1.46
Engineered multilayer ovarian tissue that secretes sex steroids and peptide hormones in response to gonadotropins. Biomaterials (2012) 1.45
Randomized comparative study between buccal mucosal and acellular bladder matrix grafts in complex anterior urethral strictures. J Urol (2008) 1.45
Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg (2012) 1.45
Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One (2010) 1.44
Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol (2007) 1.44
Principals of neovascularization for tissue engineering. Mol Aspects Med (2002) 1.44
Reprogramming of human somatic cells using human and animal oocytes. Cloning Stem Cells (2009) 1.40
Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials (2008) 1.35
Hybrid printing of mechanically and biologically improved constructs for cartilage tissue engineering applications. Biofabrication (2012) 1.34
Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int (2010) 1.33
Investigation of traumatic brain injuries using the next generation of simulated injury monitor (SIMon) finite element head model. Stapp Car Crash J (2008) 1.33
Stretch and growth: the molecular and physiologic influences of tissue expansion. Plast Reconstr Surg (2002) 1.30
Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering. Biomaterials (2010) 1.30
Amniotic fluid and placental stem cells. Methods Enzymol (2006) 1.30
Bilayered scaffold for engineering cellularized blood vessels. Biomaterials (2010) 1.29
Urethral stricture repair with an off-the-shelf collagen matrix. J Urol (2003) 1.26
Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells (2006) 1.25
Adipose tissue engineering for soft tissue regeneration. Tissue Eng Part B Rev (2010) 1.25
Differentiation of human bone marrow mesenchymal stem cells into bladder cells: potential for urological tissue engineering. Tissue Eng Part A (2010) 1.25
Oxygen generating scaffolds for enhancing engineered tissue survival. Biomaterials (2008) 1.24
Identification and characterization of bioactive factors in bladder submucosa matrix. Biomaterials (2007) 1.24
Urethral replacement using cell seeded tubularized collagen matrices. J Urol (2002) 1.24
A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials (2012) 1.21
Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A (2011) 1.21
Tissue-specific extracellular matrix coatings for the promotion of cell proliferation and maintenance of cell phenotype. Biomaterials (2009) 1.21
Cell cycle checkpoint function in bladder cancer. J Natl Cancer Inst (2003) 1.21
Complex heterogeneous tissue constructs containing multiple cell types prepared by inkjet printing technology. Biomaterials (2012) 1.21
Tubularized urethral replacement with unseeded matrices: what is the maximum distance for normal tissue regeneration? World J Urol (2008) 1.20
Sources of stem cells for regenerative medicine. Stem Cell Rev (2008) 1.17
Oxygen producing biomaterials for tissue regeneration. Biomaterials (2007) 1.16
Myogenic differentiation of human bone marrow mesenchymal stem cells on a 3D nano fibrous scaffold for bladder tissue engineering. Biomaterials (2009) 1.16
Regenerative medicine and organ transplantation: past, present, and future. Transplantation (2011) 1.14
Testicular volume: comparison of orchidometer and US measurements in dogs. Radiology (2002) 1.13
Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev (2011) 1.12
Engineering functional bladder tissues. J Tissue Eng Regen Med (2012) 1.10
Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther (2012) 1.10
Tissue-engineered conduit using urine-derived stem cells seeded bacterial cellulose polymer in urinary reconstruction and diversion. Biomaterials (2010) 1.08
Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy. J Exp Clin Assist Reprod (2004) 1.08
Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue Eng (2006) 1.07
Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res (2003) 1.06
Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. Stem Cells Dev (2005) 1.05
A tissue-engineered muscle repair construct for functional restoration of an irrecoverable muscle injury in a murine model. Tissue Eng Part A (2011) 1.05
Cyclic mechanical preconditioning improves engineered muscle contraction. Tissue Eng Part A (2008) 1.04
Tissue engineering a complete vaginal replacement from a small biopsy of autologous tissue. Transplantation (2008) 1.04
A novel use of centrifugal force for cell seeding into porous scaffolds. Biomaterials (2004) 1.04
Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online (2009) 1.03
Three-dimensional culture of hepatocytes on porcine liver tissue-derived extracellular matrix. Biomaterials (2011) 1.02